Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
Disorders of Leukocytes01:27

Disorders of Leukocytes

2.4K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.4K
Hematopoiesis01:21

Hematopoiesis

9.8K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.8K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

11.4K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
11.4K
Production of Formed Elements01:34

Production of Formed Elements

5.6K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
5.6K
Lineage Commitment01:21

Lineage Commitment

4.6K
Commitment is the  process whereby stem cells:
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Olverembatinib: A New Treatment for Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Cancers·2026
Same author

Long-term health-related quality of life and lifestyle behavior of patients with acute myeloid leukemia.

The oncologist·2026
Same author

The continuing search for effective treatments for older adults with acute myeloid leukemia.

Expert review of clinical pharmacology·2025
Same author

Rare Genetic and Uncommon Morphological Entities in Adults with Acute Myeloid Leukemia.

Current oncology reports·2025
Same author

Promising Drugs Targeting Specific Mechanisms of Deregulation in T Cell Lineage Acute Lymphoblastic Leukemia.

Oncology and therapy·2025
Same author

Examining the safety and efficacy of imetelstat in low-risk myelodysplastic syndrome.

Expert opinion on pharmacotherapy·2025

Related Experiment Video

Updated: Mar 31, 2026

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K

Understanding leukemic hematopoiesis as a complex adaptive system.

Xavier Thomas1

  • 1Xavier Thomas, Department of Hematology, Lyon-Sud Hospital, 69495 Pierre Bénite Cedex, France.

World Journal of Stem Cells
|October 31, 2015
PubMed
Summary

Hematopoiesis, the creation of blood cells, functions as a complex adaptive system. Its balance is influenced by the microenvironment, immune system, and genetic or environmental factors.

Keywords:
Acute leukemiaComplex adaptive systemHematopoiesisStem cellsTreatment

More Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.9K
A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
08:00

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

21.5K

Related Experiment Videos

Last Updated: Mar 31, 2026

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.9K
A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
08:00

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

21.5K

Area of Science:

  • Hematology
  • Systems Biology
  • Immunology

Background:

  • Hematopoiesis is a dynamic process involving the development and behavior of blood cell lineages.
  • Understanding normal and abnormal hematopoiesis is crucial for diagnosing and treating blood disorders.
  • The hematopoietic system is influenced by various internal and external factors.

Purpose of the Study:

  • To frame hematopoiesis as a complex adaptive system.
  • To explore the interplay between normal and abnormal hematopoiesis.
  • To identify key factors influencing hematopoietic development and behavior.

Main Methods:

  • Systems biology approach to analyze hematopoietic processes.
  • Integration of immunological, environmental, and genetic factors.
  • Conceptual framework development.

Main Results:

  • Hematopoiesis operates as a complex adaptive system.
  • The development of hematopoietic cell lineages represents a balance between normal and abnormal processes.
  • Microenvironmental conditions, immune system control, and hereditary/environmental events significantly influence this balance.

Conclusions:

  • Viewing hematopoiesis as a complex adaptive system provides a comprehensive understanding of its regulation.
  • Dysregulation in hematopoiesis arises from an imbalance influenced by the microenvironment, immune system, and external factors.
  • Further research into these interactions can lead to novel therapeutic strategies for hematopoietic disorders.